The Spot Sign for Predicting and Treating ICH Growth Study "STOP-IT"


Phase 2 Results

Summary of Purpose

The purpose of this study is to determine if computed tomography angiography can predict which individuals with intracerebral hemorrhage will experience significant growth in the size of the hemorrhage. For individuals who are at high risk for hemorrhage growth, the study will compare the drug recombinant activated factor VII (rFVIIa) to placebo to determine the effect of rFVIIa on intracerebral hemorrhage...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 February 2018.

1 Nov 2010 15 Dec 2008 1 Apr 2016 1 Apr 2016 1 Feb 2018 22 Sep 2017
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment